DepYmed Inc. is a New York-based cancer and rare disease therapeutic development company. DepYmed is currently developing potent inhibitors of the enzyme PTP1B (protein tyrosine phosphatase 1B) as potential novel therapeutics for HER2-positive breast cancer and Rett Syndrome.

Pharmaceutical

DepYmed

DepYmed's headquarters in Farmingdale, NY, United States

Andreas G. Grill

Peter Van Ess

Nicholas Tonks

Peter Young

Shankar Hariharan

Steve Winick

Leo Guthart

DepYmed's Leadership Team includes Peter Van Ess and 1 others.

About

People (2)

Andreas G. Grill

Peter Van Ess

Jobs